SABCS 2012

San Antonio Breast Cancer Symposium

Interviews and expert commentary from SABCS 2012 — study authors and key opinion leaders discuss the findings and their clinical implications.

SABCS 2012 logo
Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy
Audio Journal of Oncology

Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy

SAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant chemotherapy as the first line of attack against their disease, according to research from the German

18 December 2012
0:00
Local or regional breast cancer recurrences mandate adjuvant chemotherapy
Audio Journal of Oncology

Local or regional breast cancer recurrences mandate adjuvant chemotherapy

SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and

11 December 2012
0:00
Breast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapse
Audio Journal of Oncology

Breast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapse

SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 445

11 December 2012
0:00